T1	PROC 44 53	Protocolo
#1	AnnotatorNotes T1	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T2	LIVB 81 90	pacientes
#2	AnnotatorNotes T2	C0030705; Patients; Patient or Disabled Group
T3	Neg_cue 169 171	no
T4	Negated 172 181	resecable
T5	DISO 184 195	metastásico
#3	AnnotatorNotes T5	C4255448; Metastasis; Pathologic Function
T6	PROC 217 275	Protocolo abierto, multifármaco, multicéntrico, de fase II
T7	LIVB 389 398	pacientes
#4	AnnotatorNotes T7	C0030705; Patients; Patient or Disabled Group
T8	Neg_cue 465 467	no
T9	Negated 468 477	resecable
T10	DISO 480 491	metastásico
#5	AnnotatorNotes T10	C4255448; Metastasis; Pathologic Function
T11	DISO 532 577	cáncer gástrico o de la unión gastroesofágica
T12	Neg_cue 582 584	no
T13	Neg_cue 708 710	no
T14	Negated 711 720	resecable
T15	DISO 723 734	metastásico
#6	AnnotatorNotes T15	C4255448; Metastasis; Pathologic Function
T16	Age 763 776	18 años o más
T17	PROC 811 824	Peso corporal
T18	Neg_cue 836 838	No
T19	PROC 845 852	tratado
T20	Negated 845 852	tratado
T21	DISO 873 926	adenocarcinoma gástrico o de la unión gastroesofágica
T22	Neg_cue 927 929	no
T23	Negated 930 939	resecable
T24	DISO 942 953	metastásico
#7	AnnotatorNotes T24	C4255448; Metastasis; Pathologic Function
T25	DISO 967 987	lesión diana medible
T26	LIVB 1004 1016	investigador
#8	AnnotatorNotes T26	C0035173; Research Personnel; Professional or Occupational Group
T27	Duration 1079 1098	al menos 12 semanas
T28	ANAT 1122 1129	órganos
#9	AnnotatorNotes T28	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T29	ANAT 1132 1143	médula ósea
#10	AnnotatorNotes T29	C0005953; Bone Marrow; Tissue
T30	LIVB 1173 1186	Participantes
T31	PROC 1191 1195	HER2
T32	PROC 1227 1230	IHC
T33	PROC 1246 1249	ISH
T34	DISO 1253 1271	carcinoma gástrico
#11	AnnotatorNotes T34	C0699791; Stomach Carcinoma; Neoplastic Process
T35	DISO 1274 1277	GEJ
T36	DISO 1295 1325	Enfermedad metastásica del SNC
T37	Neg_cue 1339 1341	no
T38	PROC 1342 1349	tratada
T39	Negated 1342 1349	tratada
T40	DISO 1361 1385	enfermedad leptomeníngea
T41	DISO 1388 1406	compresión medular
#12	AnnotatorNotes T41	C0037926; Compression of spinal cord; Disease or Syndrome
T42	LIVB 1409 1422	Participantes
T43	DISO 1427 1434	ascitis
#13	AnnotatorNotes T43	C0003962; Ascites; Disease or Syndrome
T44	Neg_cue 1439 1441	no
T45	PROC 1465 1479	intervenciones
#14	AnnotatorNotes T45	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T46	DISO 1533 1545	tuberculosis
#15	AnnotatorNotes T46	C0041296; Tuberculosis; Disease or Syndrome | C0041327; Tuberculosis, Pulmonary; Disease or Syndrome
T47	DISO 1547 1564	infección por VIH
#16	AnnotatorNotes T47	C0019693; HIV Infections; Disease or Syndrome
T48	DISO 1567 1582	hepatitis A/B/C
T49	DISO 1586 1610	Enfermedad intercurrente
#17	AnnotatorNotes T49	C0277557; Intercurrent disease; Disease or Syndrome
T50	Neg_cue 1611 1613	no
T51	Negated 1614 1624	controlada
T52	PROC 1716 1737	tratamiento sistémico
T53	CHEM 1742 1752	esteroides
#18	AnnotatorNotes T53	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T54	PROC 1760 1786	tratamiento inmunosupresor
T55	DISO 1811 1837	neoplasia maligna primaria
#19	AnnotatorNotes T55	C1306459; Primary malignant neoplasm; Neoplastic Process
T56	PROC 1841 1852	Tratamiento
#20	AnnotatorNotes T56	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T57	Date 12 16	2022
T58	DISO 95 168	adenocarcinoma gástrico o de la unión gastroesofágica localmente avanzado
T59	PROC 594 619	extirpar mediante cirugía
T60	Negated 594 619	extirpar mediante cirugía
T61	DISO 645 707	Adenocarcinoma de la unión gastroesofágica localmente avanzado
T62	PROC 281 385	evaluar la eficacia, seguridad, tolerabilidad, farmacocinética e inmunogenicidad de nuevas combinaciones
T63	DISO 403 464	adenocarcinoma gástrico o gastroesofágico localmente avanzado
T64	PROC 804 807	ICF
T65	PROC 1027 1037	RECIST 1.1
T66	PROC 1213 1216	IHC
T67	Spec_cue 1278 1291	indeterminado
T68	DISO 1628 1666	Trastornos autoinmunes o inflamatorios
T69	Negated 1451 1490	controlar con intervenciones apropiadas
T70	DISO 1494 1518	Enfermedades infecciosas
T71	Route 1728 1737	sistémico
T72	PROC 1867 1891	agente inmuno-oncológico
T73	Quantifier_or_Qualifier 149 168	localmente avanzado
T74	Quantifier_or_Qualifier 172 181	resecable
T75	Quantifier_or_Qualifier 445 464	localmente avanzado
T76	Quantifier_or_Qualifier 468 477	resecable
T77	Quantifier_or_Qualifier 688 707	localmente avanzado
T78	Quantifier_or_Qualifier 711 720	resecable
T79	Result_or_Value 825 833	> 35 kg.
T80	Quantifier_or_Qualifier 930 939	resecable
T81	Quantifier_or_Qualifier 974 979	diana
T82	CONC 1027 1038	RECIST 1.1.
T83	CONC 1041 1045	ECOG
T84	Result_or_Value 1049 1054	0 o 1
T85	CONC 1058 1075	Esperanza de vida
T86	Observation 1102 1143	Función adecuada de órganos y médula ósea
T87	Result_or_Value 1196 1204	positivo
T88	Result_or_Value 1206 1208	3+
T89	Result_or_Value 1220 1222	2+
T90	Result_or_Value 1233 1241	positivo
T91	Quantifier_or_Qualifier 1278 1291	indeterminado
T92	Quantifier_or_Qualifier 1326 1336	progresiva
T93	Quantifier_or_Qualifier 1519 1526	activas
T94	Quantifier_or_Qualifier 1614 1624	controlada
T95	Quantifier_or_Qualifier 1667 1674	activos
T96	Quantifier_or_Qualifier 1829 1837	primaria
T97	Patient 81 90	pacientes
T98	Patient 389 398	pacientes
T99	History_of 845 852	tratado
T100	Other 1004 1016	investigador
T101	Patient 1173 1186	Participantes
T102	Patient 1409 1422	Participantes
T103	History_of 1628 1666	Trastornos autoinmunes o inflamatorios
T104	History_of 1716 1737	tratamiento sistémico
T105	History_of 1742 1752	esteroides
T106	History_of 1760 1786	tratamiento inmunosupresor
T107	History_of 1811 1828	neoplasia maligna
T108	History_of 1841 1852	Tratamiento
T109	History_of 1867 1891	agente inmuno-oncológico
T110	History_of 1829 1837	primaria
